Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, on July 5, 2018. The filing incorporates by reference a press release dated July 5, 2018, announcing a new collaboration agreement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate event rather than a financial statement.
Material Changes
The primary material event disclosed is the signing of a Collaboration Agreement with the denovoMATRIX team at Dresden University. No financial changes versus prior periods are detailed in this document.
Outlook, Risks, and Management Commentary
The filing incorporates the "Forward Looking Statements" from the attached press release into the company's Registration Statements on Form S-8 and Form F-3. The document does not contain specific management commentary on financial outlook, risks, or contingencies beyond the reference to the press release.
Investor Verification Checklist
- Verify the full terms and financial implications of the collaboration agreement with Dresden University's denovoMATRIX team.
- Review the attached press release (Exhibit 99.1) for specific details on the scope of the partnership.
- Check the referenced Registration Statements (Form S-8 and Form F-3) for the complete text of the Forward Looking Statements.
- Confirm the company's current financial status through its most recent Form 20-F or quarterly reports, as this filing contains no financial data.